Detalhe da pesquisa
1.
Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura.
Eur J Neurol
; 30(10): 3322-3331, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37489579
2.
Transcranial direct current stimulation to reduce chronic pelvic pain in endometriosis: phase II randomized controlled clinical trial.
Pain Med
; 24(7): 809-817, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882181
3.
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. / Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe.
Schmerz
; 37(1): 5-16, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36287263
4.
[Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. / Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe.
Nervenarzt
; 94(4): 306-317, 2023 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-36287216
5.
Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study.
J Headache Pain
; 24(1): 59, 2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221478
6.
Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry.
J Headache Pain
; 24(1): 135, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817093
7.
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.
Cephalalgia
; 42(4-5): 326-334, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34579559
8.
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.
Cephalalgia
; 42(4-5): 291-301, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644203
9.
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience.
J Headache Pain
; 23(1): 40, 2022 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350990
10.
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
N Engl J Med
; 379(7): 611-622, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766770
11.
Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey Study.
J Med Internet Res
; 23(11): e32707, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34766918
12.
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodies.
J Headache Pain
; 22(1): 158, 2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972502
13.
Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary.
J Headache Pain
; 22(1): 59, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157977
14.
Validation of an algorithm for automated classification of migraine and tension-type headache attacks in an electronic headache diary.
J Headache Pain
; 21(1): 75, 2020 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32532222
15.
[Headache - an Update 2018]. / Kopfschmerzen Update 2018.
Laryngorhinootologie
; 98(3): 192-217, 2019 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-30847888
16.
Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination.
J Headache Pain
; 20(1): 66, 2019 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31159727
17.
CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine.
Curr Pain Headache Rep
; 22(5): 38, 2018 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623520
18.
[Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. / Erratum zu: Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe.
Schmerz
; 37(1): 17-18, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36662297
19.
[Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. / Erratum zu: Konsensusstatement der Migräne- und Kopfschmerzgesellschaften (DMKG, ÖKSG & SKG) zur Therapiedauer der medikamentösen Migräneprophylaxe.
Nervenarzt
; 94(4): 318-319, 2023 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-36645452
20.
Structural Gray Matter Alterations in Chronic Migraine: Implications for a Progressive Disease?
Headache
; 57(3): 400-416, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28028808